ProScern® DC-T cell Proliferation Assay Publications

Jin, M., et al. (2026). “Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B. mAbs, 18(1). https://doi.org/10.1080/19420862.2026.2685362

Jambari NN, et al. (2021). “Effect of O-linked glycosylation on the antigenicity, cellular uptake and trafficking in dendritic cells of recombinant Ber e 1.” PLoS One. 2021 Apr 29;16(4):e0249876. https://doi.org/10.1371/journal.pone.0249876

Grant E. Blouse., et al. (2019). “Title of Poster: A Comprehensive In Silico And In Vitro Immunogenicity Risk Assessment of Dalcinonacog Alfa Shows No Increased Risk Compared With Wild-type FIX.“.

Steven J, et al. (2017). “In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development. Front Immunol. 2017 Oct 23;8:1361. https://doi.org/10.3389/fimmu.2017.01361